Professor | Zhiyong Luo | Asia Growth Partners

Name

Zhiyong Luo

Contact Information

luozhiyong@csu.edu.cn

Language ability

Chinese, English

Province

Hunan

University/Lab Affiliation and Title	Central South University
Faculty	Life Sciences
Academic Background & Achievements	Ph.D. in Biochemistry and Molecular Biology, Xiangya School of Medicine, Central South University Head of the Collaborative Innovation Center for Efficient Utilization of Medicinal Plant Resources and New Drug Discovery at Central South University Senior Visiting Scholar at the Cancer Research Institute, Indiana University School of Medicine, USA
Work Experience	2010.7-2014.7 - Vice Dean, School of Life Sciences, Central South University, responsible for research, disciplines, and graduate affairs
Awards	Hunan Province Natural Science Second Prize

University/Lab Affiliation and Title

Central South University

Faculty

Life Sciences

Academic Background & Achievements

Ph.D. in Biochemistry and Molecular Biology, Xiangya School of Medicine, Central South University
Head of the Collaborative Innovation Center for Efficient Utilization of Medicinal Plant Resources and New Drug Discovery at Central South University
Senior Visiting Scholar at the Cancer Research Institute, Indiana University School of Medicine, USA

Work Experience

2010.7-2014.7 - Vice Dean, School of Life Sciences, Central South University, responsible for research, disciplines, and graduate affairs

Awards

Areas of Focus	Discovery of new anticancer and anti-aging drugs from medicinal plant metabolites Synthetic biology of natural products
Publications	ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling, Su M, Luo ZY et al., 2016 Combretastatin A4 inhibits angiogenesis via suppression of VEGF-VEGFR2 signaling pathway, Su M, Luo ZY et al., 2016

Areas of Focus

Discovery of new anticancer and anti-aging drugs from medicinal plant metabolites
Synthetic biology of natural products

Publications

ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling, Su M, Luo ZY et al., 2016
Combretastatin A4 inhibits angiogenesis via suppression of VEGF-VEGFR2 signaling pathway, Su M, Luo ZY et al., 2016

Medicinal Plants Metabolites Synthetic Biology Anticancer Anti-Aging Drug Discovery Natural Products Biosynthesis Transport Proteins Gene Regulation

Yu Chen - Tongji University

Yu Chen - Tongji University

Zhiyong Luo - Central South University

View All

Personal Information